Davis SS - Search Results

1

Davis SS. Davis SS. Drug Discov Today. 2002 Dec 1;7(23):1159-61. doi: 10.1016/s1359-6446(02)02517-5. Drug Discov Today. 2002. PMID: 12547014 No abstract available.

2

The use of soluble polymers and polymer microparticles to provide improved vaccine responses after parenteral and mucosal delivery.

Davis SS. Davis SS. Vaccine. 2006 Apr 12;24 Suppl 2:S2-7-10. doi: 10.1016/j.vaccine.2005.01.102. Vaccine. 2006. PMID: 16823907 Review.

3

Development of multicomponent DNA delivery systems based upon poly(amidoamine)-PEG co-polymers.

Rackstraw BJ, Stolnik S, Davis SS, Bignotti F, Garnett MC. Rackstraw BJ, et al. Among authors: davis ss. Biochim Biophys Acta. 2002 Jul 19;1576(3):269-86. doi: 10.1016/s0167-4781(02)00347-0. Biochim Biophys Acta. 2002. PMID: 12084574

4

Formulation strategies for absorption windows.

Davis SS. Davis SS. Drug Discov Today. 2005 Feb 15;10(4):249-57. doi: 10.1016/S1359-6446(04)03351-3. Drug Discov Today. 2005. PMID: 15708743 Review.

5

PLG microparticles stabilised using enteric coating polymers as oral vaccine delivery systems.

Delgado A, Lavelle EC, Hartshorne M, Davis SS. Delgado A, et al. Among authors: davis ss. Vaccine. 1999 Jul 16;17(22):2927-38. doi: 10.1016/s0264-410x(99)00140-1. Vaccine. 1999. PMID: 10438065

6

Evaluation of bioadhesive polymers as delivery systems for nose to brain delivery: in vitro characterisation studies.

Charlton ST, Davis SS, Illum L. Charlton ST, et al. Among authors: davis ss. J Control Release. 2007 Apr 2;118(2):225-34. doi: 10.1016/j.jconrel.2006.12.014. Epub 2006 Dec 23. J Control Release. 2007. PMID: 17261340

7

Schizophrenia and drug delivery systems.

Cheng YH, Illum L, Davis SS. Cheng YH, et al. Among authors: davis ss. J Drug Target. 2000;8(2):107-17. doi: 10.3109/10611860008996856. J Drug Target. 2000. PMID: 10852342 Review.

8

Coming of age of lipid-based drug delivery systems.

Davis SS. Davis SS. Adv Drug Deliv Rev. 2004 May 7;56(9):1241-2. doi: 10.1016/j.addr.2004.02.001. Adv Drug Deliv Rev. 2004. PMID: 15109766 Review. No abstract available.

9

The stability and immunogenicity of a protein antigen encapsulated in biodegradable microparticles based on blends of lactide polymers and polyethylene glycol.

Lavelle EC, Yeh MK, Coombes AG, Davis SS. Lavelle EC, et al. Among authors: davis ss. Vaccine. 1999 Feb 12;17(6):512-29. doi: 10.1016/s0264-410x(98)00229-1. Vaccine. 1999. PMID: 10075157

10

Drug delivery in poly(lactide-co-glycolide) nanoparticles surface modified with poloxamer 407 and poloxamine 908: in vitro characterisation and in vivo evaluation.

Redhead HM, Davis SS, Illum L. Redhead HM, et al. Among authors: davis ss. J Control Release. 2001 Feb 23;70(3):353-63. doi: 10.1016/s0168-3659(00)00367-9. J Control Release. 2001. PMID: 11182205

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

473 results

Search Page

Filters